Back to Search
HERBERT HURWITZ, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1538222302Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
96-01636(NC)
Infectious Disease Physician
Internal Medicine — Infectious Disease
Code: 207RI0200X
96-01636(NC)
Research & Publications (20)
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.
PMID 19144677·Oncologist·2009
3-trial
Phase I trial of pazopanib in patients with advanced cancer.
PMID 19509175·Clin Cancer Res·2009
3-trial
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors.
PMID 16819636·Cancer Chemother Pharmacol·2007
3-trial
Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events.
PMID 17145522·Semin Oncol·2006
6-review
Long-term treatment with bevacizumab for patients with metastatic colorectal cancer: case report.
PMID 16796794·Clin Colorectal Cancer·2006
5-case
Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer.
PMID 16301832·Oncology·2005
6-review
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
PMID 15908660·J Clin Oncol·2005
3-trial
New combinations in metastatic colorectal cancer: what are our expectations?
PMID 15851788·Oncologist·2005
6-review
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.
PMID 15175435·N Engl J Med·2004
3-trial
Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.
PMID 15479481·Clin Colorectal Cancer·2004
4-observational
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.
PMID 18805651·Int J Radiat Oncol Biol Phys·2009
8-other
Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study.
PMID 18685900·J Gastrointest Surg·2009
4-observational
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials.
PMID 19064978·J Clin Oncol·2009
2-rct
Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression.
PMID 19652084·Hypertension·2009
7-preclinical
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer.
PMID 18829508·Clin Cancer Res·2008
3-trial
Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk.
PMID 18852492·Oncology·2008
8-other
Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?
PMID 19385771·J Empir Res Hum Res Ethics·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2100 ERWIN RD
DURHAM, NC 27710 - Phone
- (919) 620-4467
Quick Facts
- NPI
- 1538222302
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile